PX1 Research serves as a premier American supplier of analytical-grade Bronchogen for institutional research and laboratory investigation. Every lot undergoes rigorous HPLC and mass spectrometry testing to guarantee structural identity, conformational purity, and ultra-low endotoxin thresholds for preclinical protocols.
PX1 Research serves as a premier American supplier of analytical-grade Bronchogen for institutional research and laboratory investigation. Every lot undergoes rigorous HPLC and mass spectrometry testing to guarantee structural identity, conformational purity, and ultra-low endotoxin thresholds for preclinical protocols.
A bronchogen structural functional supplier provides research-grade bioregulatory tetrapeptides engineered specifically for in vitro and animal models investigating pulmonary tissue kinetics and gene transcription. PX1 Research supplies validated Bronchogen synthesized to strict analytical purity standards, backed by full lot-traceable COAs, high-performance liquid chromatography (HPLC) testing, and tandem mass spectrometry (MS) verification for specialized laboratory applications.
In preclinical settings, researchers evaluate structural-functional suppliers to ensure that synthetic short peptides precisely mirror the sequence integrity required for nucleosome interactions. As an established USA supplier shipping from facilities in California and Arizona, PX1 Research maintains ISO 17025 laboratory verification across our entire catalog of research peptides.
Bronchogen is a synthetic short-chain peptide bioregulator classified structurally as a tetrapeptide (Ala-Asp-Glu-Leu). With a molecular weight of approximately 446.45 g/mol, its specific amino acid sequence enables distinct conformational electrostatic interactions with the major and minor grooves of genomic DNA within respiratory epithelial models.
When sourcing through a certified bronchogen structural functional supplier, laboratories must confirm sequence linearity and mass accuracy. Proton nuclear magnetic resonance (1H-NMR) and electrospray ionization mass spectrometry (ESI-MS) are routinely employed to verify that no misfolded structural conformers or deletion sequences exist within the lyophilized cake.
Because structural integrity dictates peptide-DNA binding affinity, minor sequence shifts or racemization during solid-phase peptide synthesis (SPPS) can dramatically alter experimental outcomes. PX1 Research ensures pure L-amino acid chirality across every batch, preserving true biomimetic structural function.
In vitro data indicate that Bronchogen functions via epigenetic modulation, penetrating nuclear membranes in bronchial epithelial cells to bind specific histone-DNA complexes. Preclinical studies suggest that this interaction stimulates mRNA expression of bronchial mucosal proteins, heat shock proteins, and anti-inflammatory pathways involved in tissue homeostasis.
Rodent models examining chronic obstructive and inflammatory airway conditions show that administration of synthetic Bronchogen alters local cytokine profiles, suppressing hyper-reactivity and modulating matrix metalloproteinase (MMP) secretion. Researchers utilizing our research library hub analyze these mechanisms to understand cellular turnover and tissue repair kinetics in pulmonary biology.
Unlike non-specific peptide fragments, the Ala-Asp-Glu-Leu sequence demonstrates localized binding affinity for chromatin segments regulating surfactant production and ciliary beat frequency in primary cell cultures.
To contextualize Bronchogen's targeted profile, researchers frequently compare its activity against other short peptide bioregulators within the same structural class. While Bronchogen specifically modulates pulmonary gene expression, related short peptides exhibit distinct organotropic mechanisms.
For instance, Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) primary studied for telomerase activation and pineal gland regulation. Similarly, Vilon (Lys-Glu) functions as an immunomodulatory dipeptide targeting splenocyte and thymocyte activity, whereas Cartalax (Ala-Glu-Asp) preferentially targets connective and cartilaginous tissue matrices. Evaluating these distinct peptide motifs allows investigators to design comparative studies mapping sequence specificity against cellular response profiles.
A core duty of a professional bronchogen structural functional supplier is verifying chemical purity through multi-stage analytical chemistry. PX1 Research submits every batch to independent ISO 17025 accredited testing facilities for Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
RP-HPLC analysis provides quantitative chromatography demonstrating greater than 98% peptide purity, confirming the absence of residual TFA (trifluoroacetic acid), abbreviated sequence fragments, or synthesis side-products. Concurrently, High-Resolution Mass Spectrometry (HRMS) confirms exact monoisotopic mass and structural identity, ensuring high reproducibility across multi-phase animal and cell-based protocols.
Every shipment includes a lot-specific Certificate of Analysis (COA) displaying raw chromatograms, spectral peaks, and numerical peak area percentages so principal investigators can review verifiable analytical data before initiating assays.
Bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable in cell culture assays and live animal administration studies. Ingestion or interaction with endotoxin-contaminated peptides can cause non-specific inflammatory signaling, invalidating immunological and transcriptomic data.
PX1 Research enforces strict endotoxin screening via Chromogenic Reagent Limulus Amebocyte Lysate (LAL) assays. Our internal specification limits endotoxin levels to below 0.01 EU/μg of peptide, far exceeding standard commercial research requirements.
Additionally, all synthesis and lyophilization processes take place in sterile, cGMP-compliant cleanrooms. Final containers are sealed in vacuum-vials under nitrogen flushing to prevent oxidation, hydration, and microbial contamination during transport.
Proper reconstitution is critical to maintain the structural stability and native conformation of Bronchogen during laboratory preparation. As an acidic tetrapeptide containing aspartic and glutamic acid residues, Bronchogen exhibits excellent solubility in aqueous buffer systems.
For standard in vitro assays, researchers typically reconstitute lyophilized Bronchogen using sterile 0.9% Sodium Chloride (normal saline) or Phosphate-Buffered Saline (PBS, pH 7.4). When preparing stock solutions intended for aliquoting, the addition of 0.9% benzyl alcohol (bacteriostatic water) preserves solution integrity against opportunistic bacterial contamination during repeated syringe punctures.
Researchers should avoid high-frequency vortexing or aggressive agitation, as shear forces can disrupt peptide hydrogen bonding. Gentle swirly motion at room temperature achieves complete dissolution within seconds. Detailed handling parameters are documented in our reconstitution guide.
Lyophilized Bronchogen powder demonstrates strong long-term stability when stored under controlled thermal environments. Unopened vials stored at -20°C maintain structural purity and biological activity for up to 24 months from the date of manufacture.
Once reconstituted into aqueous solution, the peptide bond structure becomes susceptible to hydrolytic cleavage and peptide aggregation over extended durations. Reconstituted stock solutions should be maintained at 2°C to 8°C for short-term use (under 14 days), or aliquoted into single-use microcentrifuge tubes and frozen at -80°C for long-term storage.
Repeated freeze-thaw cycles must be strictly avoided, as thermal fluctuations promote ice crystal formation that degrades the primary tetrapeptide chain.
Academic institutions, biotechnology organizations, and contract research organizations (CROs) require transparent lot traceability and scalable procurement channels. PX1 Research supports large-scale preclinical studies through our dedicated wholesale program.
By manufacturing under cGMP guidelines within domestic USA facilities, PX1 Research eliminates supply chain friction, custom delays, and international import risks. Orders dispatched from our California and Arizona logistics hubs ship same-day (Monday through Friday), delivering rapid turnarounds for time-sensitive scientific schedules.
What exact sequence does Bronchogen contain?
Bronchogen is a synthetic tetrapeptide consisting of the amino acid sequence L-Alanyl-L-alpha-aspartyl-L-alpha-glutamyl-L-leucine (Ala-Asp-Glu-Leu), with a molecular formula of C18H30N4O9.
How does PX1 Research verify Bronchogen structural identity?
Every lot of Bronchogen undergoes high-performance liquid chromatography (RP-HPLC) to measure purity (>98%) and electrospray ionization mass spectrometry (ESI-MS) to verify precise molecular weight and sequence integrity.
Is Bronchogen supplied in liquid or powder form?
PX1 Research supplies Bronchogen as a sterile, lyophilized (freeze-dried) powder sealed under inert nitrogen atmosphere to maximize shelf-life and structural stability during transport.
What are the recommended endotoxin thresholds for Bronchogen?
PX1 Research enforces an endotoxin limit of <0.01 EU/μg as determined by LAL testing, ensuring the compound will not trigger non-specific inflammatory interference in primary cell cultures or animal models.
Which solvents should be used for reconstituting Bronchogen in vitro?
Bronchogen reconstitutes readily in sterile phosphate-buffered saline (PBS, pH 7.4), 0.9% sterile saline, or bacteriostatic water for laboratory research applications.
How does Bronchogen differ from Epitalon?
While both are short bioregulatory tetrapeptides, Bronchogen (Ala-Asp-Glu-Leu) targets pulmonary gene expression and bronchial epithelial cell lines, whereas Epitalon (Ala-Glu-Asp-Gly) primarily influences pineal gland activity and telomerase regulation.
Where does PX1 Research ship Bronchogen orders from?
All orders are dispatched directly from PX1 Research fulfillment facilities located in California and Arizona, offering same-day dispatch for orders placed Monday through Friday.
Can Bronchogen be purchased for human therapeutic use?
No. Bronchogen supplied by PX1 Research is strictly designated for laboratory research and in vitro/preclinical evaluation only. It is not intended for human or animal therapeutic, diagnostic, or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.